Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - STOCK-BASED COMPENSATION
Stock-based Compensation OCX - OncoCyte Corporation
6.57 M
LAST VALUE
-1.98%
2 YEAR CAGR
34.76%
5 YEAR CAGR
35.04%
10 YEAR CAGR